Heska Announces Q4 and Annual 20...( Record Revenue and I...),Health

Record Revenue and Income from Operations

LOVELAND, Colo., Feb. 26 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) today reported financial results for its fourth quarter, the three months ended December 31, 2007, and year ended December 31, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)

Heska Corporation ("Heska" or the "Company") highlights for 2007 were:

-- Total Revenue of $82.3 million - the highest total revenue in Heska

history

-- $65.9 million in Core Companion Animal Health Product Revenue,

representing 10% growth from prior year period

-- Income from Operations of $5.5 million, an 80% improvement from prior

year period

-- Net Income in all four quarters of the calendar year -- the first time

this has occurred in Heska history

-- Third consecutive year of profitable growth

"2007 was another record year for Heska. We experienced broad growth with several product areas in our Core Companion Animal Health segment increasing compared to 2006. We also had a solid year in our Other Vaccines, Pharmaceuticals and Products area, with product revenue up 25% from 2006," said Robert Grieve, Heska's Chairman and CEO. "In the fourth quarter of 2007, we continued the steady growth of our Core Companion Animal Health segment with 11% product revenue growth compared to prior year period. As we have previously predicted, the fourth quarter of 2006 presented a difficult comparison for us due to the impact of an allergy-related patent portfolio sale in December 2006. As we look to 2008, we are particularly excite
'/>"/>